Digital Biomarkers Market Size, Share & Trends Report

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors), By Clinical Practice, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-989-3
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2017 - 2020
Industry: Healthcare

Market Segmentation

Digital Biomarkers Type Outlook (Revenue, Million, 2017 - 2030)
- Wearable
- Mobile based Applications
- Sensors
- Others
Digital Biomarkers Clinical Practice Outlook (Revenue, Million, 2017 - 2030)
- Diagnostic digital biomarkers
- Monitoring digital biomarkers
- Predictive and Prognostic digital biomarkers
- Other's (Safety, Pharmaco dynamics/ Response, Susceptibility)
Digital Biomarkers Therapeutic Area Outlook (Revenue, Million, 2017 - 2030)
- Cardiovascular and metabolic disorders (CVMD)
- Respiratory disorders
- Psychiatric disorders
- Sleep & Movement Disease
- Neurological disorders
- Musculoskeletal disorders
- Others (Diabetes, Pain Management)
Digital Biomarkers End-Use Outlook (Revenue, Million, 2017 - 2030)
- Healthcare companies
- Healthcare Providers
- Payers
- Others (Patient, caregivers)
Digital Biomarkers Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
  - Digital Biomarkers Type Outlook
    - Wearable
    - Mobile based Applications
    - Sensors
    - Others
  - Digital Biomarkers Clinical Practice Outlook
    - Diagnostic digital biomarkers
    - Monitoring digital biomarkers
    - Predictive and Prognostic digital biomarkers
    - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
  - Digital Biomarkers Therapeutic Area Outlook
    - Cardiovascular and metabolic disorders (CVMD)
    - Respiratory disorders
    - Psychiatric disorders
    - Sleep & Movement Disease
    - Neurological disorders
    - Musculoskeletal disorders
    - Others (Diabetes, Pain Management)
  - Digital Biomarkers End-Use Outlook
    - Healthcare companies
    - Healthcare Providers
    - Payers
    - Others (Patient, caregivers)
  - U.S.
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Canada
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
- Europe
  - Digital Biomarkers Type Outlook
    - Wearable
    - Mobile based Applications
    - Sensors
    - Others
  - Digital Biomarkers Clinical Practice Outlook
    - Diagnostic digital biomarkers
    - Monitoring digital biomarkers
    - Predictive and Prognostic digital biomarkers
    - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
  - Digital Biomarkers Therapeutic Area Outlook
    - Cardiovascular and metabolic disorders (CVMD)
    - Respiratory disorders
    - Psychiatric disorders
    - Sleep & Movement Disease
    - Neurological disorders
    - Musculoskeletal disorders
    - Others (Diabetes, Pain Management)
  - Digital Biomarkers End-Use Outlook
    - Healthcare companies
    - Healthcare Providers
    - Payers
    - Others (Patient, caregivers)
  - U.K.
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Germany
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Netherlands
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Italy
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Switzerland
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
- Asia Pacific
  - Digital Biomarkers Type Outlook
    - Wearable
    - Mobile based Applications
    - Sensors
    - Others
  - Digital Biomarkers Clinical Practice Outlook
    - Diagnostic digital biomarkers
    - Monitoring digital biomarkers
    - Predictive and Prognostic digital biomarkers
    - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
  - Digital Biomarkers Therapeutic Area Outlook
    - Cardiovascular and metabolic disorders (CVMD)
    - Respiratory disorders
    - Psychiatric disorders
    - Sleep & Movement Disease
    - Neurological disorders
    - Musculoskeletal disorders
    - Others (Diabetes, Pain Management)
  - Digital Biomarkers End-Use Outlook
    - Healthcare companies
    - Healthcare Providers
    - Payers
    - Others (Patient, caregivers)
  - Japan
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - India
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - China
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Australia
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - South Korea
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
- Latin America
  - Digital Biomarkers Type Outlook
    - Wearable
    - Mobile based Applications
    - Sensors
    - Others
  - Digital Biomarkers Clinical Practice Outlook
    - Diagnostic digital biomarkers
    - Monitoring digital biomarkers
    - Predictive and Prognostic digital biomarkers
    - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
  - Digital Biomarkers Therapeutic Area Outlook
    - Cardiovascular and metabolic disorders (CVMD)
    - Respiratory disorders
    - Psychiatric disorders
    - Sleep & Movement Disease
    - Neurological disorders
    - Musculoskeletal disorders
    - Others (Diabetes, Pain Management)
  - Digital Biomarkers End-Use Outlook
    - Healthcare companies
    - Healthcare Providers
    - Payers
    - Others (Patient, caregivers)
  - Brazil
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Mexico
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
- Middle East & Africa
  - Digital Biomarkers Type Outlook
    - Wearable
    - Mobile based Applications
    - Sensors
    - Others
  - Digital Biomarkers Clinical Practice Outlook
    - Diagnostic digital biomarkers
    - Monitoring digital biomarkers
    - Predictive and Prognostic digital biomarkers
    - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
  - Digital Biomarkers Therapeutic Area Outlook
    - Cardiovascular and metabolic disorders (CVMD)
    - Respiratory disorders
    - Psychiatric disorders
    - Sleep & Movement Disease
    - Neurological disorders
    - Musculoskeletal disorders
    - Others (Diabetes, Pain Management)
  - Digital Biomarkers End-Use Outlook
    - Healthcare companies
    - Healthcare Providers
    - Payers
    - Others (Patient, caregivers)
  - South Africa
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)
  - Israel
    - Digital Biomarkers Type Outlook
      - Wearable
      - Mobile based Applications
      - Sensors
      - Others
    - Digital Biomarkers Clinical Practice Outlook
      - Diagnostic digital biomarkers
      - Monitoring digital biomarkers
      - Predictive and Prognostic digital biomarkers
      - Other's (Safety, Pharma co dynamics/ Response, Susceptibility)
    - Digital Biomarkers Therapeutic Area Outlook
      - Cardiovascular and metabolic disorders (CVMD)
      - Respiratory disorders
      - Psychiatric disorders
      - Sleep & Movement Disease
      - Neurological disorders
      - Musculoskeletal disorders
      - Others (Diabetes, Pain Management)
    - Digital Biomarkers End-Use Outlook
      - Healthcare companies
      - Healthcare Providers
      - Payers
      - Others (Patient, caregivers)

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2017 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.